Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Post-Authorization Safety Study (PASS) of MOVENTIG® (Naloxegol) Drug Utilization in Selected European Populations

NCT02813148 is registered in ClinicalTrials.gov with Kyowa Kirin Pharmaceutical Development Ltd as lead sponsor.

NCT NCT02813148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02813148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Post-Authorization Safety Study (PASS) of MOVENTIG® (Naloxegol) Drug Utilization in Selected European Populations
Lead sponsor
Kyowa Kirin Pharmaceutical Development Ltd
Phase
Observational
Overall status
Completed
Start date
August 31, 2015
Completion date
January 31, 2020
Enrollment
17,254 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

opioid induced constipation